aztreonam has been researched along with netilmicin in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (25.00) | 18.7374 |
| 1990's | 5 (20.83) | 18.2507 |
| 2000's | 9 (37.50) | 29.6817 |
| 2010's | 4 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Dumas, JL; Köhler, T; Reinhardt, A; Ricou, B; Rohner, P; van Delden, C; Wood, P | 1 |
| Castanheira, M; Jones, RN; Mendes, RE; Sader, HS; Toleman, MA; Walsh, TR | 1 |
| Bajolet, O; Berthelot, P; Bingen, E; Couetdic, G; Favre, R; Grattard, F; Hocquet, D; Husson, MO; Jeannot, K; Mariani-Kurkdjian, P; Marty, N; Plésiat, P; Roussel-Delvallez, M | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Kirikae, T; Kitao, T; Miyoshi-Akiyama, T | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Girlich, D; Nordmann, P; Poirel, L | 1 |
| Courvalin, P; Coyne, S; Guigon, G; Périchon, B | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Cipriani, P; Filadoro, F; Giordano, A; Magni, A | 1 |
| Keller, N; Overbeek, BP; Raponi, G; Rozenberg-Arska, M; Torensma, R; Verhoef, J | 1 |
| Becopoulos, T; Constantinides, C; Georgoulias, D; Kosmidis, J; Stathakis, H | 1 |
| Dorigo, MT; Miglioli, PA | 1 |
| Legakis, N; Michalitsianos, D; Tumah, H; Velonaki, A | 1 |
| Carnimeo, N; Grasso, R; Lella, A; Musci, C; Pirelli, E; Valerio, G | 1 |
| Becker, A; Burdge, RE; Ellington, LL; Greenberg, RN; Perry, CR; Vossen, MK | 1 |
| Benonisen, E; Dibb, WL; Digranes, A; Salveson, A | 1 |
| Cox, FR; Flournoy, DJ | 1 |
| Cipriani, P; Giordano, A; Magni, A; Trancassini, M | 2 |
24 other study(ies) available for aztreonam and netilmicin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Bacterial; Humans; Longitudinal Studies; Pneumonia, Ventilator-Associated; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections | 2007 |
Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital.
Topics: Acinetobacter; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Brazil; Codon, Terminator; Cross Infection; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Open Reading Frames; Plasmids; Pseudomonas putida; Transcription, Genetic | 2007 |
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactams; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Genotype; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.
Topics: Acetylation; Acetyltransferases; Aminoglycosides; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Integrons; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; DNA, Bacterial; DNA, Complementary; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, MDR; Metals, Heavy; Microbial Sensitivity Tests; Mutation; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Influence of aztreonam-netilmicin association on outer membrane proteins of P. aeruginosa strains.
Topics: Aztreonam; Bacterial Outer Membrane Proteins; Cell Membrane Permeability; Drug Synergism; Drug Therapy, Combination; Electrophoresis, Polyacrylamide Gel; Netilmicin; Porins; Pseudomonas aeruginosa | 1991 |
Immunization of mice with antibiotic-treated Escherichia coli results in enhanced protection against challenge with homologous and heterologous bacteria.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Blood Bactericidal Activity; Ceftriaxone; Ciprofloxacin; Complement System Proteins; Enzyme-Linked Immunosorbent Assay; Epitopes; Escherichia coli; Escherichia coli Infections; Female; Immunization; Immunoglobulin G; Immunoglobulin M; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Netilmicin; Opsonin Proteins; Phagocytosis | 1991 |
Acute prostatitis: which antibiotic to use first.
Topics: Acute Disease; Anti-Bacterial Agents; Aztreonam; Cefuroxime; Humans; Male; Netilmicin; Prostate; Prostatitis | 1990 |
Antibiotic levels in aqueous and vitreous humor after intraocular administration.
Topics: Ampicillin; Animals; Aqueous Humor; Aztreonam; Drug Therapy, Combination; Male; Netilmicin; Piperacillin; Rabbits; Vitreous Body | 1989 |
In vitro effect of combinations of netilmicin with aztreonam against Pseudomonas aeruginosa.
Topics: Aztreonam; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa | 1987 |
Effects of aztreonam and netilmicin upon alveolar macrophage function.
Topics: Acid Phosphatase; Aztreonam; Bacterial Infections; Humans; L-Lactate Dehydrogenase; Macrophages; Netilmicin; Phagocytosis; Potassium; Pulmonary Alveoli | 1986 |
Antibiotic stability in an implantable pump.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Clindamycin; Drug Stability; Gentamicins; Humans; Infusion Pumps; Microbial Sensitivity Tests; Netilmicin; Osteomyelitis; Tobramycin | 1986 |
Ro 17-2301: in vitro comparison with aztreonam, imipenem, ceftazidime, cefotaxime and netilmicin.
Topics: Acinetobacter; Anti-Bacterial Agents; Aztreonam; Ceftazidime; Enterobacteriaceae; Gentamicins; Imipenem; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Thienamycins | 1985 |
In vitro susceptibilities of mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients against azthreonam, netilmicin and piperacillin.
Topics: Anti-Bacterial Agents; Aztreonam; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Netilmicin; Piperacillin; Pseudomonas aeruginosa | 1984 |
Subinhibitory concentrations of antibacterial drugs and Pseudomonas aeruginosa virulence factors.
Topics: Alginates; Anti-Bacterial Agents; Aztreonam; Fluoroquinolones; Glucuronic Acid; Hexuronic Acids; Naphthyridines; Netilmicin; Pancreatic Elastase; Pseudomonas aeruginosa; Virulence | 1993 |
Outer membrane proteins and lipopolysaccharide changes after exposure of Pseudomonas aeruginosa to antibacterial drugs.
Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Outer Membrane Proteins; Fluoroquinolones; Lipopolysaccharides; Microbial Sensitivity Tests; Naphthyridines; Netilmicin; Pseudomonas aeruginosa | 1993 |